About
Technology
Issues
FAQ
Links
Official Page
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.